Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Unspecified Adult Solid Tumor, Protocol Specific 2 Male Urogenital Diseases 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Rectal Neoplasms 1 Prevention of Colorectal Cancer 1 Precancerous Conditions 1 Polyps 1 Ovarian Neoplasms 1 Non-melanoma Skin Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Inflammation 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Breast Cancer Risk 1 Arsenic Poisoning 1 Adenomatous Polyps 1

Interventions

Cyclophosphamide 176 Rituximab 164 fludarabine phosphate 97 Peripheral Blood Stem Cell Transplantation 95 Filgrastim 73 Etoposide 67 Radiotherapy 63 Mycophenolic Acid 62 Whole-Body Irradiation 58 Tacrolimus 49 Melphalan 49 Cyclosporine 49 Busulfan 47 Lenalidomide 45 Antilymphocyte Serum 39 Vincristine 37 Prednisone 37 Cytarabine 37 fludarabine 35 Methotrexate 33 Carmustine 32 obinutuzumab 31 Doxorubicin 30 Bendamustine Hydrochloride 30 Methylprednisolone 27 ibritumomab tiuxetan 25 Cord Blood Stem Cell Transplantation 25 sargramostim 24 Bortezomib 24 Granulocyte Colony-Stimulating Factor 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, Follicular × Selenium × Clear all

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡